Annual Retained Earnings
-$1.70 B
-$1.00 B-143.92%
December 31, 2023
Summary
- As of February 20, 2025, IRWD annual retained earnings is -$1.70 billion, with the most recent change of -$1.00 billion (-143.92%) on December 31, 2023.
- During the last 3 years, IRWD annual retained earnings has fallen by -$232.56 million (-15.86%).
- IRWD annual retained earnings is now -796.37% below its all-time high of -$189.50 million, reached on December 31, 2007.
Performance
IRWD Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.70 B
+$3.65 M+0.21%
September 30, 2024
Summary
- As of February 20, 2025, IRWD quarterly retained earnings is -$1.70 billion, with the most recent change of +$3.65 million (+0.21%) on September 30, 2024.
- Over the past year, IRWD quarterly retained earnings has stayed the same.
- IRWD quarterly retained earnings is now -598.51% below its all-time high of -$243.37 million, reached on December 31, 2008.
Performance
IRWD Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
IRWD Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -143.9% | 0.0% |
| 3 y3 years | -15.9% | -81.3% |
| 5 y5 years | -6.8% | -81.3% |
IRWD Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -143.9% | at low | -161.3% | +0.8% |
| 5 y | 5-year | -143.9% | at low | -161.3% | +0.8% |
| alltime | all time | -796.4% | at low | -598.5% | +0.8% |
Ironwood Pharmaceuticals Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$1.70 B(-0.2%) |
| Jun 2024 | - | -$1.70 B(+0.1%) |
| Mar 2024 | - | -$1.70 B(+0.2%) |
| Dec 2023 | -$1.70 B(+143.9%) | -$1.70 B(+0.1%) |
| Sep 2023 | - | -$1.70 B(-0.9%) |
| Jun 2023 | - | -$1.71 B(+163.2%) |
| Mar 2023 | - | -$650.66 M(-6.6%) |
| Dec 2022 | -$696.38 M(-25.7%) | -$696.38 M(-6.6%) |
| Sep 2022 | - | -$745.24 M(-6.3%) |
| Jun 2022 | - | -$795.56 M(-4.5%) |
| Mar 2022 | - | -$832.64 M(-11.2%) |
| Dec 2021 | -$937.61 M(-36.0%) | -$937.61 M(-4.2%) |
| Sep 2021 | - | -$978.98 M(-5.4%) |
| Jun 2021 | - | -$1.03 B(-27.4%) |
| Mar 2021 | - | -$1.43 B(-2.7%) |
| Dec 2020 | -$1.47 B(-6.8%) | -$1.47 B(-2.9%) |
| Sep 2020 | - | -$1.51 B(-2.2%) |
| Jun 2020 | - | -$1.54 B(-1.6%) |
| Mar 2020 | - | -$1.57 B(-0.2%) |
| Dec 2019 | -$1.57 B(-1.2%) | -$1.57 B(-3.0%) |
| Sep 2019 | - | -$1.62 B(-1.3%) |
| Jun 2019 | - | -$1.64 B(-0.6%) |
| Mar 2019 | - | -$1.65 B(+3.7%) |
| Dec 2018 | -$1.59 B(+21.6%) | -$1.59 B(+1.0%) |
| Sep 2018 | - | -$1.58 B(+12.4%) |
| Jun 2018 | - | -$1.40 B(+3.7%) |
| Mar 2018 | - | -$1.35 B(+3.3%) |
| Dec 2017 | -$1.31 B(+9.8%) | -$1.31 B(-0.9%) |
| Sep 2017 | - | -$1.32 B(+2.5%) |
| Jun 2017 | - | -$1.29 B(+3.6%) |
| Mar 2017 | - | -$1.24 B(+4.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2016 | -$1.19 B(+7.4%) | -$1.19 B(+1.1%) |
| Sep 2016 | - | -$1.18 B(+2.9%) |
| Jun 2016 | - | -$1.15 B(+1.9%) |
| Mar 2016 | - | -$1.12 B(+1.2%) |
| Dec 2015 | -$1.11 B(+14.7%) | -$1.11 B(+1.3%) |
| Sep 2015 | - | -$1.10 B(+4.5%) |
| Jun 2015 | - | -$1.05 B(+4.8%) |
| Mar 2015 | - | -$1.00 B(+3.4%) |
| Dec 2014 | -$967.45 M(+24.4%) | -$967.45 M(+4.0%) |
| Sep 2014 | - | -$929.80 M(+4.7%) |
| Jun 2014 | - | -$887.81 M(+7.3%) |
| Mar 2014 | - | -$827.45 M(+6.4%) |
| Dec 2013 | -$777.83 M(+54.0%) | -$777.83 M(+7.2%) |
| Sep 2013 | - | -$725.84 M(+9.3%) |
| Jun 2013 | - | -$664.07 M(+10.9%) |
| Mar 2013 | - | -$598.92 M(+18.6%) |
| Dec 2012 | -$505.02 M(+16.8%) | -$505.02 M(+9.5%) |
| Sep 2012 | - | -$461.16 M(-9.4%) |
| Jun 2012 | - | -$508.80 M(+8.7%) |
| Mar 2012 | - | -$467.99 M(+8.2%) |
| Dec 2011 | -$432.39 M(+17.6%) | -$432.39 M(+1.6%) |
| Sep 2011 | - | -$425.42 M(+5.1%) |
| Jun 2011 | - | -$404.79 M(+4.9%) |
| Mar 2011 | - | -$385.94 M(+5.0%) |
| Dec 2010 | -$367.54 M(+16.8%) | -$367.54 M(+5.7%) |
| Jun 2010 | - | -$347.62 M(+5.2%) |
| Mar 2010 | - | -$330.48 M(+5.1%) |
| Dec 2009 | -$314.56 M(+29.2%) | -$314.56 M(+8.5%) |
| Sep 2009 | - | -$290.04 M(+19.2%) |
| Dec 2008 | -$243.37 M(+28.4%) | -$243.37 M |
| Dec 2007 | -$189.50 M | - |
FAQ
- What is Ironwood Pharmaceuticals annual retained earnings?
- What is the all time high annual retained earnings for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals annual retained earnings year-on-year change?
- What is Ironwood Pharmaceuticals quarterly retained earnings?
- What is the all time high quarterly retained earnings for Ironwood Pharmaceuticals?
- What is Ironwood Pharmaceuticals quarterly retained earnings year-on-year change?
What is Ironwood Pharmaceuticals annual retained earnings?
The current annual retained earnings of IRWD is -$1.70 B
What is the all time high annual retained earnings for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high annual retained earnings is -$189.50 M
What is Ironwood Pharmaceuticals annual retained earnings year-on-year change?
Over the past year, IRWD annual retained earnings has changed by -$1.00 B (-143.92%)
What is Ironwood Pharmaceuticals quarterly retained earnings?
The current quarterly retained earnings of IRWD is -$1.70 B
What is the all time high quarterly retained earnings for Ironwood Pharmaceuticals?
Ironwood Pharmaceuticals all-time high quarterly retained earnings is -$243.37 M
What is Ironwood Pharmaceuticals quarterly retained earnings year-on-year change?
Over the past year, IRWD quarterly retained earnings has changed by $0.00 (0.00%)